TrialAntimicrobial agents and chemotherapy1998

Population pharmacokinetic study of amikacin administered once or twice daily to febrile, severely neutropenic adults.

M Tod et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.